Science
Consolidation of pathology networks
Head of Pathology Services Consolidation at NHS Improvement, David Wells, sets out the progress made on the 29 networks and looks at the next steps and future plans.
Fast molecular diagnostics for tight turnaround times
Turnaround times for diagnostic tests can be an obstacle to effectively controlling healthcare associated infections (HAI), such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenemase producing Enterobacteriaceae (CPE), with delayed results leading to ward closures and cancelled operations.
August: journal-based learning
Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl
News
-
From haematology to stand-up comedy
Dave Spikey may be a famous comic and actor now, but in the late sixties he was starting a biomedical science career.
-
The Big Question: 'Does biomedical science still represent a career for life?'
Three people voice their opinions on a career in biomedical science.
-
Cyan under the microscope
This month: Cyan
Science
The duffy blood group system
Head of RCI Laboratory Martin Maley gives an introduction to the Duffy blood group system.
The test tube: a symbolic story
While the test tube is hardly the most imposing item of glassware on a scientist’s workbench, its symbolic power is second to none.
My lab: laboratory on the rock
IBMS Gibraltar Branch Secretary Norbert Sene gives a guided tour of the Pathology Department at Saint Bernard’s Hospital in Gibraltar.
Latest Jobs
IBMS Twitter
Technology
Laboratory industry trade show
The Lab Innovations trade show returns to the NEC, Birmingham, on 31 October and 1 November 2018.
Resources
Clinical chemistry classics: tumour markers
This series continues with a brief review of pioneering work in the development, analysis and clinical application of important tumour markers, with two examples from the CA serum series – CA125 and CA15-3.
